IMI will hold webinars on IMI2 – Call 13 from 27 November to 15 December inclusive.
All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.
The webinar on IMI’s rules and procedures will include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions. IMI will also hold a dedicated webinar for small and medium-sized enterprises (SMEs). This will cover elements of the different Call topics that may be of particular relevance for SMEs, as well as a presentation of IMI’s rules and procedures with a focus on aspects that are most important for SMEs.
Registration is free but obligatory via the links given for each webinar. When you register, you will receive an automatic confirmation e-mail with your own personal web link and dial-in number which you should use on the day.
IMI rules & procedures
Thursday 7 December, 15:00 - 16:30
Opportunities for SMEs in IMI2 – Call 13
Thursday 7 December, 10:00 – 11:30
Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative
Monday 27 November, 15:00 - 16:30
Human tumour microenvironment immunoprofiling
Friday 1 December, 10:30 - 12:00
Mitochondrial dysfunction in neurodegeneration
Monday 4 December, 10:30 - 12:00
Translational safety biomarker pipeline (TRANSBIOLINE): enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Monday 4 December, 15:00 - 16:30
Pilot programme on a clinical compound bank for repurposing. This programme includes the following topics: cardiovascular diseases and diabetes; respiratory diseases; neurodegenerative diseases; rare/orphan diseases
Wednesday 6 December, 10:30 - 12:00
A sustainable European induced pluripotent stem cell platform
Monday 11 December, 10:30 - 12:00
CONCEPTION – continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
Monday 11 December, 15:00 - 16:30
Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
Tuesday 12 December, 15:00 - 16:30
Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Thursday 14 December, 10:30 - 12:00
Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
Thursday 14 December, 15:00 - 16:30
The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Friday 15 December, 10:30 - 12:00
Genome-environment interactions in inflammatory skin disease
Friday 15 December, 15:00 - 16:30